Saturday, July 11, 2026

Drug profile · INN

menadiol sodium diphosphate

menadiol sodium diphosphate (KAPPADIONE) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — menadiol sodium diphosphate
US status
approved
Class
Route
INJECTION
Patents
0
Programs
0
Data quality
0.84

Quick answer

menadiol sodium diphosphate (KAPPADIONE) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN menadiol sodium diphosphate
Brand KAPPADIONE
Route INJECTION
Formulation INJECTABLE

Approval history

Authority Status Date
FDA approved

Frequently asked questions

What is menadiol sodium diphosphate?

menadiol sodium diphosphate (KAPPADIONE) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for menadiol sodium diphosphate?

KAPPADIONE is a marketed brand name for menadiol sodium diphosphate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of menadiol sodium diphosphate?

menadiol sodium diphosphate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.